Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
posTErs<br />
Posters<br />
Page 444 PROgRammE & ExhibiTiOn guidE • WCB 2012<br />
abS. numbER<br />
> MRI-dummy markers of MRI-guided HDR brachytherapy for interstitial<br />
prostate and intracavitary GYN cancers<br />
J. Schindel (USA), M. Muruganandham, A. Eagle, M. Hewitt,<br />
T. Stockman, C. Pigge, Y. Kim PO-339<br />
> Dosimetric impact of NOT correcting for the distal shift reported<br />
in varian tandem and ring (T&R) applicators<br />
O. Craciunescu (USA), J. Sánchez Mazón, L. Lan, J. Maurer, B. Steffey,<br />
J. Cai, J. Adamson, J. Chino PO-340<br />
> Intranasal mold HDR brachytherapy for nasal vestibule cancer:<br />
analysis of heterogeneity correction<br />
E.F. Crandley (USA), B. Libby, K.A. Reardon, K. Ding, A. Martof,<br />
S.H. Benedict, P.W. Read PO-341<br />
> Measurements of an electronic brachytherapy source with a<br />
brachytherapy dose verification phantom<br />
T. Pike (USA), L. DeWerd, J. Micka PO-342<br />
> Comparision of TG-43 and Acuros Dose calculation algorithm for<br />
various applicators used in HDR gyn brachytherapy<br />
J. Swamidas (India), U. Mahantshetty, S.K. Shrivatava, D.D. Deshpande PO-343<br />
> In-vivo dosimetry in HDR brachytherapy:the effect of temperature<br />
variation and simulated position changes<br />
O. Hayman (United Kingdom), A. Palmer, S. Williams PO-344<br />
> Inter-seed attenuation in prostate I-125 seed implant brachytherapy:<br />
experimental and clinical investigation<br />
P. Bownes (United Kingdom), J. Mason, B. Al-Qaisieh, A. Henry,<br />
D. Thwaites PO-345<br />
> Measurements around an electronic brachytherapy source using<br />
lithium formate EPR dosimeters and GafChromic film<br />
E. Adolfsson (Sweden), S. White, G. Landry, G. Alm Carlsson,<br />
H. Gustafsson, E. Lund, B. Reniers, F. Verhaegen, A. Carlsson Tedgren PO-346<br />
Posters<br />
abS. numbER<br />
> Are tissue and applicator heterogeneities effect important in<br />
Brachytherapy TPS? A real case<br />
A. Pereira (Portugal), R. Pirraco, T. Viterbo, L. Salgado, L. Carvalho,<br />
L. Trigo, J. Lencart PO-347<br />
> Evaluation of the trachea inhomogenety effect on dose calculations<br />
of esophagus HDR brachytherapy<br />
S.M. Hosseini Daghigh, R. Jaberi (Iran Islamic Republic of), S.R. Mahdavi,<br />
S.M.R. Aghamiri, H. Baghani, E. Boroghani, R. Eidi PO-348<br />
> Positive outcomes of T cell skin lymphoma using HDR brachytherapy<br />
for complex skin geometry<br />
R. Zakikhani, E. Galhardo, C. Luo, S. Gagne, R. Dugal, Y. Zhu, Z. Wang,<br />
M. Albert (USA) PO-349<br />
> Intense learning outcomes based brachytherapy training for radiation<br />
oncology medical physicists<br />
E. Flower (Australia) PO-350<br />
> Radiation safety: source position indicator as a quality assurance tool<br />
in high dose rate (HDR) brachytherapy<br />
E.O. Oyekunle (Nigeria), R.I. Obed PO-351<br />
> Modulation restrictions do not necessarily improve treatment plan<br />
quality for HDR prostate brachytherapy<br />
M. Balvert (The Netherlands), B. Gorissen, D. den Hertog, A. Hoffmann PO-352<br />
> Clinical assessment of the HDR CAPRI applicator<br />
B. Steffey (USA), O. Craciunescu, J. Cai, J. Adamson, J. Chino PO-353<br />
> Dosimetric impacts of upgrading from plato to OncentraBrachy in a<br />
high volume prostate HDR brachytherapy center<br />
F. Lacroix (Canada), J. Morrier, M.C. Lavallée, S. Aubin, W. Foster,<br />
A.G. Martin, E. Vigneault, N. Varfalvy, L. Beaulieu PO-354<br />
> Brachytherapy dataset quality assurance using the gamma-index<br />
method<br />
Y. Yang (USA), N.L. Gagne, C.S. Melhus, M.J. Rivard PO-355<br />
WCB 2012 • PROgRammE & ExhibiTiOn guidE Page 445<br />
posTErs<br />
WCB
Change language